Valuation: 3billion, Inc.

Market Cap 185B 135M 119M 112M 102M 191M 12.94B 192M 1.34B 520M 6.59B 506M 495M 21.43B P/E 2025
-107x
P/E 2026 * -
Enterprise Value 168M 122K 108K 102K 92.66K 173K 11.76M 175K 1.22M 472K 5.98M 460K 450K 19.47M EV / Sales 2025
49x
EV / Sales 2026 * -
Free-Float
75.33%
Yield 2025 *
-
Yield 2026 * -
1 day+23.27%
1 week+42.86%
Current month+11.97%
1 month+7.01%
3 months-3.49%
6 months-54.93%
Current year-68.18%
1 week 4,575
Extreme 4575
6,100
1 month 4,020
Extreme 4020
6,100
Current year 4,020
Extreme 4020
18,690
1 year 4,020
Extreme 4020
20,100
3 years 3,025
Extreme 3025
20,100
5 years 3,025
Extreme 3025
20,100
10 years 3,025
Extreme 3025
20,100
Manager TitleAgeSince
Chief Executive Officer 45 2016-10-09
Director of Finance/CFO 46 2020-09-30
Chief Operating Officer 44 2019-01-31
Director TitleAgeSince
Director/Board Member 52 2020-03-19
Director/Board Member 45 2016-10-09
Director/Board Member 44 2016-10-09
Date Insider Type Main position Quantity % Market Cap. Importance
4/16/25 Others

Chief Financial Officer

44,000 0.1387%
3/7/25 Exercice

Chief Financial Officer

40,000 0.1262%
3/7/25 Exercice 10,000 0.0316%
Change 5-day change 1-year change 3-year change Capi.($)
+23.27%+42.86%-22.56% - 135M
+2.45%+3.94%+391.27%+127.90% 4.62B
+3.71%+1.17%+125.31%+468.60% 4.45B
+7.06%+14.35%+41.95%+106.45% 3.52B
+14.80%+15.03%+314.61%+717.28% 2.81B
+2.50%+22.28%-7.77%-15.52% 2.52B
+0.83%+6.59%+48.11% - 1.69B
-0.58%+4.78%+29.52%+61.14% 1.13B
-0.34%+1.44%+171.14%-20.70% 1.1B
+5.08%+4.75%-20.77%+84.39% 625M
Average +5.81%+7.65%+107.08%+191.19% 2.26B
Weighted average by Cap. +4.65%+5.14%+162.09%+246.79%

Financials

2025 2026 *
Net sales 10.8B 7.89M 6.94M 6.54M 5.97M 11.16M 757M 11.25M 78.5M 30.42M 385M 29.62M 28.98M 1.25B -
Net income -5.8B -4.24M -3.73M -3.51M -3.21M -5.99M -407M -6.04M -42.16M -16.34M -207M -15.91M -15.56M -674M -
Net Debt -16.9B -12.34M -10.86M -10.24M -9.34M -17.47M -1.18B -17.6M -123M -47.6M -603M -46.35M -45.34M -1.96B -
Logo 3billion, Inc.
3Billion Inc is a Korea-based company principally engaged in the provision of genetic testing services. The Company is principally engaged in the provision of rare genetic disease diagnostic testing services. The Company is also engaged in the research and development of technology that automatically reads the pathogenicity of numerous genetic variants found in the genome.
Employees
-
Date Price Change Volume
26-09-23 ₩5,800.00 +23.27% 3,785,681
26-09-22 ₩4,705.00 0.00% 386,634
26-09-21 ₩4,705.00 -1.36% 365,088
26-09-18 ₩4,770.00 +10.67% 1,118,000
26-09-17 ₩4,310.00 +6.16% 883,981

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A394800 Stock